PTC Therapeutics

Patent cliffs & loss of exclusivity

A biopharmaceutical company focused on discovery and development of small-molecule drugs to treat genetic and rare diseases.

Company

AngelList URLhttps://angel.co/ptc-therapeutics
CAGE Code1XUQ0
Legal NamePTC Therapeutics Inc.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/ptc-therapeutics
Facebook URLhttps://www.facebook.com/pages/PTC-Therapeutics/106075039423774
Fax Number908 222 7231
Full Address350 North Bernardo Avenue Mountain View, CA 94043

2 upcoming patent cliffs

DrugIngredientTypeCliff
  1. EMFLAZADEFLAZACORTSmall mol.Jun 2026
  2. EMFLAZADEFLAZACORTSmall mol.Jun 2026
  3. EMFLAZADEFLAZACORTSmall mol.Jun 2026
  4. EMFLAZADEFLAZACORTSmall mol.Jun 2026
  5. EMFLAZADEFLAZACORTSmall mol.Jun 2026
  6. SEPHIENCESEPIAPTERINSmall mol.Mar 2042
  7. SEPHIENCESEPIAPTERINSmall mol.Mar 2042
  8. KEBILIDIeladocagene exuparvovec-tneqBiologic

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

PTC Therapeutics — patent cliffs & loss of exclusivity | CliffBio